In 2022, a study published in Science Translational Medicine reported the successful prevention of metastasis formation in mice by implanting brain metastatic breast cancer cells into mice and treating them with FAK inhibitors developed by Pfizer and Verastem (38). Here, PTK2 is linked to breast carcinoma.